Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4848544
Max Phase: Preclinical
Molecular Formula: C36H38F3N7O4S
Molecular Weight: 607.78
Molecule Type: Unknown
Associated Items:
ID: ALA4848544
Max Phase: Preclinical
Molecular Formula: C36H38F3N7O4S
Molecular Weight: 607.78
Molecule Type: Unknown
Associated Items:
Canonical SMILES: NCCCCc1cn(-c2ccc(-c3nc(CCc4ccc(-c5ccccc5)cc4)cs3)c(OCCN3CCNC3=O)c2)nn1.O=C(O)C(F)(F)F
Standard InChI: InChI=1S/C34H37N7O2S.C2HF3O2/c35-17-5-4-8-28-23-41(39-38-28)30-15-16-31(32(22-30)43-21-20-40-19-18-36-34(40)42)33-37-29(24-44-33)14-11-25-9-12-27(13-10-25)26-6-2-1-3-7-26;3-2(4,5)1(6)7/h1-3,6-7,9-10,12-13,15-16,22-24H,4-5,8,11,14,17-21,35H2,(H,36,42);(H,6,7)
Standard InChI Key: YLGHGRRTKGFYQM-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 607.78 | Molecular Weight (Monoisotopic): 607.2729 | AlogP: 5.53 | #Rotatable Bonds: 14 |
Polar Surface Area: 111.19 | Molecular Species: BASE | HBA: 8 | HBD: 2 |
#RO5 Violations: 2 | HBA (Lipinski): 9 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 13.44 | CX Basic pKa: 10.20 | CX LogP: 5.40 | CX LogD: 2.80 |
Aromatic Rings: 5 | Heavy Atoms: 44 | QED Weighted: 0.16 | Np Likeness Score: -1.34 |
1. Revuelto A, de Lucio H, García-Soriano JC, Sánchez-Murcia PA, Gago F, Jiménez-Ruiz A, Camarasa MJ, Velázquez S.. (2021) Efficient Dimerization Disruption of Leishmania infantum Trypanothione Reductase by Triazole-phenyl-thiazoles., 64 (9.0): [PMID:33945281] [10.1021/acs.jmedchem.1c00206] |
2. de Lucio H, Revuelto A, Carriles AA, de Castro S, García-González S, García-Soriano JC, Alcón-Calderón M, Sánchez-Murcia PA, Hermoso JA, Gago F, Camarasa MJ, Jiménez-Ruiz A, Velázquez S.. (2022) Identification of 1,2,3-triazolium salt-based inhibitors of Leishmania infantum trypanothione disulfide reductase with enhanced antileishmanial potency in cellulo and increased selectivity., 244 [PMID:36332553] [10.1016/j.ejmech.2022.114878] |
Source(1):